Nanofluidic device delivered controlled doses
People with chronic diseases like arthritis, diabetes and heart disease may one day forego the daily regimen of pills and, instead, receive a scheduled dosage of medication through a grape-sized implant that is remotely controlled.
Researchers from Houston Methodist successfully delivered continuous, predetermined dosages of two chronic disease medications using a nanochannel delivery system (nDS) that they remotely controlled using Bluetooth technology. The nDS device provides controlled release of drugs without the use of pumps, valves or a power supply for possibly up to year without a refill for some patients. This technology will be tested in space next year.
A proof-of-concept paper recently published in Lab on a Chip (online June 25) explains how the Houston Methodist nanomedicine researchers accomplished long-term delivery of drugs for rheumatoid arthritis and high blood pressure, medications that are often administered at specific times of the day or at varying dosages based on patient needs.
“We see this universal drug implant as part of the future of health care innovation. Some chronic disease drugs have the greatest benefit of delivery during overnight hours when it’s inconvenient for patients to take oral medication. This device could vastly improve their disease management and prevent them from missing doses, simply with a medical professional overseeing their treatment remotely,” said Alessandro Grattoni, Ph.D., corresponding author and chair of the department of nanomedicine at Houston Methodist Research Institute.
Grattoni and the Houston Methodist researchers have worked on implantable nanochannel delivery systems to regulate the delivery of a variety of therapies for medical issues ranging from HIV-prevention to cancer. As basic research progresses with the remote-controlled device, the Houston Methodist technology is planned for extreme remote communication testing on the International Space Station in 2020. The team hopes that one day the system will be widely available to clinicians to treat patients remotely via telemedicine. This could provide both an improvement in the patients’ quality of life and a reduction of cost to the health care system.
The battery-powered implant contains a microchip that is Bluetooth enabled and relies on wireless communication. To prove the technology worked as planned, the microchip was programmed for three different drug release settings – standard, decreased and increased. With each setting, a specific voltage was applied to a silicon nanochannel within the implant to control drug release.
Current drug delivery devices, such as pain or insulin implants, rely on pumping mechanisms or external ports and typically need refills every couple of months. The Houston Methodist device is implanted under the skin and uses a nanofluidic membrane made with similar technology used in the silicon semiconductor industry. The drug dosage and schedule can be tailored to each patient, and the implant delivers the drugs for many months, even a year, before refills are needed.
According to the CDC, chronic diseases are among the most common, costly and preventable of all medical problems.
The Latest on: Drug delivery implant
via Google News
The Latest on: Drug delivery implant
- CMS issues final rule on healthcare technology access for seniorson January 13, 2021 at 7:19 am
The rule is meant to ease undue burden for innovators and speed access to potentially lifesaving technologies.
- North America Medical Plastic Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Type ; Application, and Countryon January 12, 2021 at 3:45 am
Reportlinker.com announces the release of the report "North America Medical Plastic Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Type ; Application, and Country" - Medical ...
- Ocular Implants Market to Reach $7.94 Billion by 2026 Driven by Recent Technological Advancements in Product R&D, says Fortune Business Insights™on January 6, 2021 at 4:57 pm
The global “ocular implants market” is expected to gain traction on account of technological advancements in the ocular market. Fortune Business Insights offers a detailed overview of the global ...
- Rashid Hospital doctors perform special implant procedure for an epilepsy patienton January 6, 2021 at 3:54 am
Since the successful procedure, H.A. has been able to breathe a sigh of relief as she now prepares herself for programming the device and leading a life with minimum seizures that are less severe and ...
- THE Best New Spine Technologies for 2020on January 4, 2021 at 11:58 am
The companies with the BEST new spine care technologies for 2020 are: CONGRATULATIONS to all of our winners for 2020! Rewarding Innovation and Perspiration. This annual award rewa ...
- Flowonix Receives Infusion of $33M to Close Out Series B Roundon January 4, 2021 at 11:21 am
Flowonix Medical, an implantable drug delivery device specialist, has raised $33 million in a series B round. The Mount Olive, NJ-based company closed the financing with the help of SWK Holdings. The ...
- MIT implant delivers drugs and the light that activates themon December 29, 2020 at 4:00 pm
MIT scientists are working on an alternative, that delivers both light and a light-activated drug directly to the target area. So-called "photoswitchable" drugs contain light-sensitive molecules ...
- Medgadget’s Best Medical Technologies of 2018on December 27, 2020 at 4:00 pm
EyeGate II iontophoresis drug delivery system uses electric current ... scientists have created and tested an electronic implant that stimulates the stomach to create a feeling of satiety.
- Medical Implant, Packaging Materials Lighten Upon December 25, 2020 at 4:00 pm
The lightweight materials used to manufacture soft tissue implants, including absorbable ones and those used for drug delivery, are textiles, usually made of polyester and polypropylene. The materials ...
- Adenosinergic Systemon December 21, 2020 at 4:00 pm
 Aiming to circumvent the peripheral side effects of adenosine, novel drug delivery techniques including stem cell implants, adenosine releasing synthetic polymers, focal paracrine delivery of ...
via Bing News